Lathi Vijay K
Insider CIK 1340806 · WHRT 10% owner · CMRX 10% owner · MEIP 10% owner · CNCE 10% owner · IRTC Director, 10% owner · RLYP · VSAR 10% owner · DRTX 10% owner · ITRM 10% owner · HARP Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| HARP Harpoon Therapeutics, Inc. | D To issuer deriv | 2024-03-11 | 2024-03-11 | 85,750 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | D To issuer deriv | 2024-03-11 | 2024-03-11 | 686,000 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | D To issuer deriv | 2024-03-11 | 2024-03-11 | 299,430 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | D To issuer | 2024-03-11 | 2024-03-11 | 1,463,386 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | D To issuer | 2024-03-11 | 2024-03-11 | 395,783 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | D To issuer | 2024-03-11 | 2024-03-11 | 10,000 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | P Buy deriv | 2023-10-25 | 2023-10-27 | 85,750 | — | $0 | 85,750 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | P Buy deriv | 2023-10-25 | 2023-10-27 | 686,000 | — | $0 | 686,000 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | P Buy | 2023-10-25 | 2023-10-27 | 171,500 | — | $0 | 395,783 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | P Buy | 2023-10-25 | 2023-10-27 | 1,372,000 | — | $0 | 1,463,386 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion deriv | 2018-05-30 | 2018-05-31 | 148,603 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion deriv | 2018-05-30 | 2018-05-31 | 466,793 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion deriv | 2018-05-30 | 2018-05-31 | 178,230 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion | 2018-05-30 | 2018-05-31 | 148,603 | — | $0 | 793,626 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion | 2018-05-30 | 2018-05-31 | 466,793 | — | $0 | 466,793 | SEC↗ |
| ITRM Iterum Therapeutics plc | P Buy | 2018-05-30 | 2018-05-31 | 278,062 | $13.00 | $3.61M | 1,071,688 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion | 2018-05-30 | 2018-05-31 | 178,230 | — | $0 | 645,023 | SEC↗ |
| ITRM Iterum Therapeutics plc | P Buy | 2018-05-30 | 2018-05-31 | 384,615 | $13.00 | $5.00M | 384,615 | SEC↗ |
| IRTC iRhythm Technologies, Inc. | S Sale | 2018-03-09 | 2018-03-12 | 84,380 | $66.40 | $5.60M | 0 | SEC↗ |
| IRTC iRhythm Technologies, Inc. | S Sale | 2018-03-08 | 2018-03-12 | 2,659 | $67.17 | $178.6K | 84,380 | SEC↗ |
| IRTC iRhythm Technologies, Inc. | S Sale | 2018-03-08 | 2018-03-12 | 26,979 | $66.50 | $1.79M | 87,039 | SEC↗ |
| IRTC iRhythm Technologies, Inc. | S Sale | 2018-02-22 | 2018-02-26 | 45,723 | $65.61 | $3.00M | 114,018 | SEC↗ |
| IRTC iRhythm Technologies, Inc. | S Sale | 2018-02-21 | 2018-02-22 | 44,000 | $64.12 | $2.82M | 159,741 | SEC↗ |
| IRTC iRhythm Technologies, Inc. | S Sale | 2018-02-20 | 2018-02-22 | 125,000 | $61.81 | $7.73M | 203,741 | SEC↗ |
| IRTC iRhythm Technologies, Inc. | S Sale | 2017-12-07 | 2017-12-07 | 72,000 | $52.78 | $3.80M | 328,741 | SEC↗ |
| IRTC iRhythm Technologies, Inc. | S Sale | 2017-12-07 | 2017-12-07 | 6,354 | $52.15 | $331.4K | 400,741 | SEC↗ |
| IRTC iRhythm Technologies, Inc. | S Sale | 2017-12-06 | 2017-12-07 | 14,216 | $52.29 | $743.4K | 407,095 | SEC↗ |
| IRTC iRhythm Technologies, Inc. | S Sale | 2017-12-05 | 2017-12-07 | 57,430 | $52.41 | $3.01M | 421,311 | SEC↗ |
| IRTC iRhythm Technologies, Inc. | S Sale | 2017-11-17 | 2017-11-20 | 125,000 | $52.11 | $6.51M | 478,741 | SEC↗ |
| IRTC iRhythm Technologies, Inc. | S Sale | 2017-11-16 | 2017-11-20 | 100,000 | $52.09 | $5.21M | 603,741 | SEC↗ |
| IRTC iRhythm Technologies, Inc. | X Exercise deriv | 2017-09-13 | 2017-09-15 | 72,389 | — | $0 | 0 | SEC↗ |
| IRTC iRhythm Technologies, Inc. | X Exercise | 2017-09-13 | 2017-09-15 | 72,389 | — | $0 | 738,354 | SEC↗ |
| IRTC iRhythm Technologies, Inc. | S Sale | 2017-09-13 | 2017-09-15 | 10 | $45.82 | $458 | 738,344 | SEC↗ |
| IRTC iRhythm Technologies, Inc. | S Sale | 2017-09-13 | 2017-09-15 | 34,603 | $49.51 | $1.71M | 703,741 | SEC↗ |
| IRTC iRhythm Technologies, Inc. | S Sale | 2017-06-08 | 2017-06-08 | 292,000 | $38.04 | $11.11M | 665,965 | SEC↗ |
| IRTC iRhythm Technologies, Inc. | S Sale | 2017-06-06 | 2017-06-08 | 138,624 | $36.63 | $5.08M | 957,965 | SEC↗ |
| IRTC iRhythm Technologies, Inc. | S Sale | 2017-05-16 | 2017-05-16 | 130,000 | $35.25 | $4.58M | 1,096,589 | SEC↗ |
| IRTC iRhythm Technologies, Inc. | S Sale | 2017-05-16 | 2017-05-16 | 80,000 | $36.26 | $2.90M | 1,226,589 | SEC↗ |
| IRTC iRhythm Technologies, Inc. | S Sale | 2017-05-15 | 2017-05-16 | 235,000 | $34.25 | $8.05M | 1,306,589 | SEC↗ |
| IRTC iRhythm Technologies, Inc. | S Sale | 2017-05-12 | 2017-05-16 | 200,000 | $34.25 | $6.85M | 1,541,589 | SEC↗ |
| IRTC iRhythm Technologies, Inc. | A Award deriv | 2017-04-26 | 2017-07-07 | 3,007 | — | $0 | 3,007 | SEC↗ |
| IRTC iRhythm Technologies, Inc. | A Award | 2017-04-26 | 2017-07-07 | 1,405 | — | $0 | 1,405 | SEC↗ |
| IRTC iRhythm Technologies, Inc. | C Conversion deriv | 2016-10-25 | 2016-10-25 | 610,136 | — | $0 | 0 | SEC↗ |
| IRTC iRhythm Technologies, Inc. | C Conversion deriv | 2016-10-25 | 2016-10-25 | 190,154 | — | $0 | 0 | SEC↗ |
| IRTC iRhythm Technologies, Inc. | C Conversion deriv | 2016-10-25 | 2016-10-25 | 155,548 | — | $0 | 0 | SEC↗ |
| IRTC iRhythm Technologies, Inc. | C Conversion deriv | 2016-10-25 | 2016-10-25 | 72,389 | — | $0 | 0 | SEC↗ |
| IRTC iRhythm Technologies, Inc. | C Conversion | 2016-10-25 | 2016-10-25 | 1,716,589 | — | $0 | 1,716,589 | SEC↗ |
| IRTC iRhythm Technologies, Inc. | P Buy | 2016-10-25 | 2016-10-25 | 25,000 | $17.00 | $425.0K | 1,741,589 | SEC↗ |
| MEIP MEI Pharma, Inc. | S Sale | 2015-03-24 | 2015-03-26 | 1,601,390 | $1.97 | $3.15M | 0 | SEC↗ |
| VSAR Versartis, Inc. | S Sale | 2014-12-18 | 2014-12-22 | 150,000 | $19.01 | $2.85M | 2,409,374 | SEC↗ |
| MEIP MEI Pharma, Inc. | S Sale | 2014-12-09 | 2014-12-10 | 70,081 | $6.01 | $421.2K | 1,601,390 | SEC↗ |
| MEIP MEI Pharma, Inc. | S Sale | 2014-12-08 | 2014-12-10 | 9,004 | $6.05 | $54.5K | 1,671,471 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | D To issuer | 2014-11-17 | 2014-11-18 | 3,028,439 | — | $0 | 0 | SEC↗ |
| VSAR Versartis, Inc. | S Sale | 2014-11-11 | 2014-11-13 | 800,000 | $19.37 | $15.50M | 2,559,374 | SEC↗ |
| VSAR Versartis, Inc. | S Sale | 2014-09-29 | 2014-10-01 | 12,556 | $20.02 | $251.4K | 3,359,374 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion deriv | 2014-03-27 | 2014-03-28 | 8,439,620 | — | $0 | 0 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion deriv | 2014-03-27 | 2014-03-28 | 1,349,433 | — | $0 | 0 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion deriv | 2014-03-27 | 2014-03-28 | 20,942,466 | — | $0 | 0 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion deriv | 2014-03-27 | 2014-03-28 | 3,546,094 | — | $0 | 0 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion deriv | 2014-03-27 | 2014-03-28 | 3,050,019 | — | $0 | 0 | SEC↗ |
| VSAR Versartis, Inc. | X Exercise deriv | 2014-03-27 | 2014-03-28 | 759,565 | — | $0 | 0 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion deriv | 2014-03-27 | 2014-03-28 | 759,565 | — | $0 | 0 | SEC↗ |
| VSAR Versartis, Inc. | P Buy | 2014-03-27 | 2014-03-28 | 60,000 | $21.02 | $1.26M | 3,371,930 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion | 2014-03-27 | 2014-03-28 | 1,821,084 | — | $0 | 1,821,084 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion | 2014-03-27 | 2014-03-28 | 66,049 | — | $0 | 3,311,930 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion | 2014-03-27 | 2014-03-28 | 308,356 | — | $0 | 3,245,881 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion | 2014-03-27 | 2014-03-28 | 117,342 | — | $0 | 2,937,525 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion | 2014-03-27 | 2014-03-28 | 265,219 | — | $0 | 2,820,183 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion | 2014-03-27 | 2014-03-28 | 733,880 | — | $0 | 2,554,964 | SEC↗ |
| CMRX CHIMERIX INC | J Other | 2014-03-18 | 2014-03-20 | 700,000 | — | $0 | 1,543,394 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-21 | 442,478 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-21 | 77,522 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-19 | 2014-02-21 | 13,721 | — | $0 | 107,327 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-19 | 2014-02-21 | 78,315 | — | $0 | 93,606 | SEC↗ |
| MEIP MEI Pharma, Inc. | S Sale | 2013-11-21 | 2013-11-25 | 365,000 | $8.25 | $3.01M | 1,680,475 | SEC↗ |
| RLYP Relypsa Inc | C Conversion deriv | 2013-11-20 | 2013-11-20 | 259,676 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | C Conversion deriv | 2013-11-20 | 2013-11-20 | 497,093 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | J Other deriv | 2013-11-20 | 2013-11-20 | 25,977 | — | $0 | 25,977 | SEC↗ |
| RLYP Relypsa Inc | M Exercise deriv | 2013-11-20 | 2013-11-20 | 25,977 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | C Conversion deriv | 2013-11-20 | 2013-11-20 | 378,773 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | C Conversion deriv | 2013-11-20 | 2013-11-20 | 541,960 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | C Conversion deriv | 2013-11-20 | 2013-11-20 | 125,067 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | J Other deriv | 2013-11-20 | 2013-11-20 | 17,671 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | C Conversion | 2013-11-20 | 2013-11-20 | 497,093 | — | $0 | 497,093 | SEC↗ |
| RLYP Relypsa Inc | C Conversion | 2013-11-20 | 2013-11-20 | 125,067 | — | $0 | 1,924,626 | SEC↗ |
| RLYP Relypsa Inc | C Conversion | 2013-11-20 | 2013-11-20 | 378,773 | — | $0 | 1,257,599 | SEC↗ |
| RLYP Relypsa Inc | C Conversion | 2013-11-20 | 2013-11-20 | 541,960 | — | $0 | 1,799,559 | SEC↗ |
| RLYP Relypsa Inc | C Conversion | 2013-11-20 | 2013-11-20 | 381,733 | — | $0 | 878,826 | SEC↗ |
| RLYP Relypsa Inc | M Exercise | 2013-11-20 | 2013-11-20 | 25,977 | $9.18 | $238.5K | 1,950,603 | SEC↗ |
| RLYP Relypsa Inc | F Tax w/h | 2013-11-20 | 2013-11-20 | 21,691 | $11.00 | $238.6K | 1,928,912 | SEC↗ |
| RLYP Relypsa Inc | P Buy | 2013-11-20 | 2013-11-20 | 185,978 | $11.00 | $2.05M | 2,114,890 | SEC↗ |
| MEIP MEI Pharma, Inc. | S Sale | 2013-05-08 | 2013-05-08 | 100,000 | $8.45 | $845.0K | 2,045,475 | SEC↗ |
| MEIP MEI Pharma, Inc. | S Sale | 2013-05-06 | 2013-05-08 | 100,000 | $8.70 | $870.0K | 2,145,475 | SEC↗ |
| MEIP MEI Pharma, Inc. | S Sale | 2013-04-19 | 2013-04-22 | 157,300 | $8.43 | $1.33M | 2,245,475 | SEC↗ |
| MEIP MEI Pharma, Inc. | S Sale | 2013-04-18 | 2013-04-22 | 100,000 | $8.57 | $857.0K | 2,402,775 | SEC↗ |
| MEIP MEI Pharma, Inc. | S Sale | 2013-02-19 | 2013-02-20 | 300,000 | $6.80 | $2.04M | 2,502,775 | SEC↗ |
| MEIP MEI Pharma, Inc. | S Sale | 2013-02-15 | 2013-02-20 | 197,225 | $6.60 | $1.30M | 2,802,775 | SEC↗ |
| WHRT WORLD HEART CORP | D To issuer deriv | 2012-08-02 | 2012-08-06 | 2,341,920 | $0.10 | $234.2K | 0 | SEC↗ |
| WHRT WORLD HEART CORP | D To issuer | 2012-08-02 | 2012-08-06 | 6,063,603 | — | $0 | 0 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | C Conversion deriv | 2012-07-24 | 2012-07-26 | 17,953,008 | — | $0 | 0 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | C Conversion | 2012-07-24 | 2012-07-26 | 2,244,126 | — | $0 | 2,244,126 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | P Buy | 2012-07-24 | 2012-07-26 | 784,313 | $9.00 | $7.06M | 3,028,439 | SEC↗ |